BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.40M | -2.12M | -2.78M | -3.67M | -3.50M |
| Total Depreciation and Amortization | 255.00K | 276.00K | 284.00K | 310.00K | 272.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 3.00K |
| Total Other Non-Cash Items | 479.00K | 1.19M | 1.88M | 1.79M | 1.79M |
| Change in Net Operating Assets | -1.54M | -639.00K | 111.00K | -277.00K | -922.00K |
| Cash from Operations | -3.21M | -1.29M | -508.00K | -1.84M | -2.37M |
| Capital Expenditure | -1.24M | -1.41M | -1.57M | -1.29M | -478.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.00K | -- | -- | -- | -- |
| Cash from Investing | -1.32M | -1.41M | -1.57M | -1.29M | -478.00K |
| Total Debt Issued | 864.00K | 65.00K | 65.00K | 65.00K | 65.00K |
| Total Debt Repaid | -14.00K | 43.00K | 35.00K | 33.00K | -27.00K |
| Issuance of Common Stock | 2.86M | 3.46M | 2.93M | 2.75M | 3.01M |
| Repurchase of Common Stock | -1.28M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.01M | 35.00K | 323.00K | 1.39M | 1.61M |
| Cash from Financing | 4.44M | 3.61M | 3.35M | 4.23M | 4.66M |
| Foreign Exchange rate Adjustments | 94.00K | -69.00K | -80.00K | -26.00K | -128.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.00K | 840.00K | 1.19M | 1.07M | 1.69M |